1. Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension

   • M. A. van Baak
   • T. L. Kho
   • K. H. Rahn

   Originals Pages: 377 - 382

2. Effects of oral chlordemethyldiazepam on plasma adrenaline and noradrenaline and cardiovascular reactivity in preoperative patients

   • G. B. Picotti
   • O. Corli
   • M. O. Carruba

   Originals Pages: 383 - 388

3. Comparative effects of alinidine and propranolol in ischaemic heart disease

   • J. Schurmans
   • J. Piessens
   • H. De Geest

   Originals Pages: 389 - 396

4. Within patient comparison of prazosin and UK-33,274. A new alpha-adrenoceptor-antagonist

   • P. W. de Leeuw
   • J. J. Ligthart
   • W. H. Birkenhäger

   Originals Pages: 397 - 401

5. In vitro and in vivo down-regulation of human plateletα ₂-adrenoceptors by clonidine

   • O. -E. Brodde
   • M. Anlauf
   • K. D. Bock

   Originals Pages: 403 - 409

6. Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension

   • T. Lüscher
   • J. Havelka
   • W. Vetter

   Originals Pages: 411 - 415

7. The electrocardiographic and anticholinergic effects of trazodone and imipramine in man

   • C. D. Burgess
   • T. K. Hames
   • C. F. George

   Originals Pages: 417 - 421

8. Dipyridamole treatment in chronic obstructive airways disease: Effect on platelet regeneration time

   • E. Tremoli
   • L. Bertoli
   • C. R. Sirtori

   Originals Pages: 423 - 427

9. Disposition of pulse dose methylprednisolone in adult and paediatric patients with the nephrotic syndrome

   • B. M. Assael
   • G. Banfi
   • W. J. Jusko

   Originals Pages: 429 - 433

10. Should erythromycin dose be altered in haemodialysis patients?

    • A. Iliopoulou
    • K. Downey
    • P. Turner

    Originals Pages: 435 - 440

11. The use of pain scales in assessing the efficacy of analgesics in post-operative dental pain

    • R. A. Seymour

    Originals Pages: 441 - 444

12. Population pharmacokinetic parameters in patients treated with oral mexiletine

    • S. Vozeh
    • G. Katz
    • F. Follath

    Originals Pages: 445 - 451

13. The influence of protein binding on disopyramide clearance

    • S. M. Bryson
    • J. R. Lawrence
    • D. J. Sumner

    Originals Pages: 453 - 456

14. Pethidine binding to blood cells and plasma proteins in old and young subjects

    • L. Holmberg
    • I. Odar-Cederlöf
    • L. O. Boréus

    Originals Pages: 457 - 461

15. Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy

    • T. Suzuki
    • S. Higa
    • A. Nakajima

    Originals Pages: 463 - 468